Specifically, Pommier et al. [235] have shown that the loss of TRIM33 enhanced tumor aggressiveness by promoting mitotic defects that led to chromosomal abnormalities (increased aneuploidy and chromosome rearrangements). The gene discussed is TRIM33; the disease is neoplasm.